The Potential of Lonidamine in Combination with Chemotherapy and Physical Therapy in Cancer Treatment

Cisplatin in cancer therapy: Molecular mechanisms of action

Dasari, S., & Bernard Tchounwou, P. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.025 · Cited by 5,537 · see citing works

The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs

Johnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00597 · Cited by 2,489 · see citing works

Photodynamic therapy – mechanisms, photosensitizers and combinations

Kwiatkowski, S., Knap, B., Przystupski, D., Saczko, J., Kędzierska, E., Knap-Czop, K., Kotlińska, J., Michel, O., Kotowski, K., & Kulbacka, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.049 · Cited by 2,173 · see citing works

Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies

Octavia, Y., Tocchetti, C. G., Gabrielson, K. L., Janssens, S. P., Crijns, H. J. G. M., & Moens, A. L. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.03.006 · Cited by 1,425 · see citing works

Targeting cancer metabolism: a therapeutic window opens

Heiden, M. G. V. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3504 · Cited by 1,409 · see citing works

Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer

DeBerardinis, R. J., & Cheng, T. (2010) · Oncogene · doi:10.1038/onc.2009.358 · Cited by 1,365 · see citing works

Mechanisms of action of arsenic trioxide.

Miller, W. H., Schipper, H. M., Lee, J. S., Singer, J. W., & Waxman, S. (2002) · PubMed · Cited by 939 · see citing works

Heat Shock Proteins: Endogenous Modulators of Apoptotic Cell Death

Garrido, C., Gurbuxani, S. K., Ravagnan, L., & Kroemer, G. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5427 · Cited by 777 · see citing works

A microenvironmental model of carcinogenesis

Gatenby, R. A., & Gillies, R. J. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2255 · Cited by 725 · see citing works

Metabolic targets for cancer therapy

Galluzzi, L., Kepp, O., Heiden, M. G. V., & Kroemer, G. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4145 · Cited by 705 · see citing works

Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity

Kridel, S. J., Axelrod, F. T., Rozenkrantz, N., & Smith, J. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3645 · Cited by 610 · see citing works

DNA Cross-Linking Agents as Antitumor Drugs

Rajski, S. R., & Williams, R. M. (1998) · Chemical Reviews · doi:10.1021/cr9800199 · Cited by 596 · see citing works

Hyperthermia adds to chemotherapy

Issels, R. D. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.07.038 · Cited by 545 · see citing works

Oncogenic K‐Ras decouples glucose and glutamine metabolism to support cancer cell growth

Gaglio, D., Metallo, C. M., Gameiro, P. A., Hiller, K., Danna, L. S., Balestrieri, C., Alberghina, L., Stephanopoulos, G., & Chiaradonna, F. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.56 · Cited by 492 · see citing works

NMR and Molecular Modeling Investigation of the Mechanism of Activation of the Antitumor Drug Temozolomide and Its Interaction with DNA

Denny, B. J., Wheelhouse, R. T., Stevens, M. F. G., Tsang, L. L. H., & Slack, J. A. (1994) · Biochemistry · doi:10.1021/bi00197a003 · Cited by 442 · see citing works

Tumor pH controls the <i>in vivo</i> efficacy of weak acid and base chemotherapeutics

Gerweck, L. E., Vijayappa, S., & Kozin, S. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0024 · Cited by 362 · see citing works

Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells

Reuter, S., Eifes, S., Dicato, M. A., Aggarwal, B. B., & Diederich, M. F. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.07.031 · Cited by 337 · see citing works

Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis

Cheng, G., Zhang, Q., Pan, J., Lee, Y., Ouari, O., Hardy, M., Zielonka, M., Myers, C. R., Zielonka, J., Weh, K. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10042-1 · Cited by 251 · see citing works

Molecular targets of curcumin.

Lin, J.-K. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-46401-5_10 · Cited by 230 · see citing works

Mechanism of antineoplastic activity of lonidamine

Nath, K., Guo, L., Nancolas, B., NELSON, D. S., Shestov, A. A., Lee, S., Roman, J., Zhou, R., Leeper, D. B., Halestrap, A. P., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.08.001 · Cited by 213 · see citing works

Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore

Ravagnan, L., Marzo, I., Costantini, P., Susín, S. A., Zamzami, N., Petit, P. X., Hirsch, F., Goulbern, M., Poupon, M., Miccoli, L., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202625 · Cited by 207 · see citing works

The Potential Role of Systemic Buffers in Reducing Intratumoral Extracellular pH and Acid-Mediated Invasion

Silva, A. S., Yunes, J. A., Gillies, R. J., & Gatenby, R. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2394 · Cited by 205 · see citing works

The roles of glucose metabolic reprogramming in chemo- and radio-resistance

Lin, J., Xia, L., Liang, J., Han, Y., Wang, H., Oyang, L., Tan, S., Tian, Y., Rao, S., Chen, X., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1214-z · Cited by 191 · see citing works

Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine

Guo, L., Shestov, A. A., Worth, A. J., Nath, K., NELSON, D. S., Leeper, D. B., Glickson, J. D., & Blair, I. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.697516 · Cited by 181 · see citing works

Development of EGFR-Targeted Polymer Blend Nanocarriers for Combination Paclitaxel/Lonidamine Delivery To Treat Multi-Drug Resistance in Human Breast and Ovarian Tumor Cells

Milane, L. S., Duan, Z., & Amiji, M. M. (2010) · Molecular Pharmaceutics · doi:10.1021/mp1002653 · Cited by 161 · see citing works

Two New Male Contraceptives Exert Their Effects by Depleting Germ Cells Prematurely from the Testis1

Cheng, C. Y., Silvestrini, B., Grima, J., Mo, M., Zhu, L.-J., Johansson, E., Saso, L., Leone, M.-G., Palmery, M., & Mruk, D. D. (2001) · Biology of Reproduction · doi:10.1095/biolreprod65.2.449 · Cited by 154 · see citing works

DNA repair in personalized brain cancer therapy with temozolomide and nitrosoureas

Kaina, B., & Christmann, M. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.04.007 · Cited by 141 · see citing works

Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance in vitro

Khdair, A. A., Handa, H., Mao, G., & Panyam, J. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.017 · Cited by 129 · see citing works

Heat shock proteins and the heat shock response during hyperthermia and its modulation by altered physiological conditions

Horowitz, M., & Robinson, S. D. M. (2007) · Progress in brain research · doi:10.1016/s0079-6123(06)62021-9 · Cited by 128 · see citing works

Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy

Cervantes-Madrid, D., Romero, Y., & Dueñas‐González, A. (2015) · BioMed Research International · doi:10.1155/2015/690492 · Cited by 119 · see citing works

Direct and indirect photodynamic therapy effects on the cellular and molecular components of the tumor microenvironment

Sanabria, L. M., Rodríguez, M. E., Cogno, I. S., Vittar, N. B. R., Pansa, M. F., Lamberti, M. J., & Rivarola, V. A. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.10.001 · Cited by 117 · see citing works

Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia

Zhou, J., Zhang, Y., Li, J., Li, X., Hou, J., Zhao, Y., Liu, X., Han, X., Hu, L., Wang, S., et al. (2009) · Blood · doi:10.1182/blood-2009-07-230805 · Cited by 116 · see citing works

Nuclear PKM2 contributes to gefitinib resistance via upregulation of STAT3 activation in colorectal cancer

Li, Q., Zhang, D., Chen, X., He, L., Li, T., Xu, X., & Li, M. (2015) · Scientific Reports · doi:10.1038/srep16082 · Cited by 114 · see citing works

Prolonged Biologically Active Colonic Tissue Levels of Curcumin Achieved After Oral Administration—A Clinical Pilot Study Including Assessment of Patient Acceptability

Irving, G. R. B., Howells, L. M., Sale, S., Kralj‐Hans, I., Atkin, W. S., Clark, S. K., Britton, R. G., Jones, D. J. L., Scott, E. N., Berry, D. P., et al. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0281 · Cited by 111 · see citing works

Effects of matrine against the growth of human lung cancer and hepatoma cells as well as lung cancer cell migration

Zhang, Y., Zhang, H., Yu, P., Liu, Q., Liu, K., Duan, H., Luan, G., Yagasaki, K., & Zhang, G. (2009) · Cytotechnology · doi:10.1007/s10616-009-9211-2 · Cited by 108 · see citing works

Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways

Li, N., Zhang, C.-X., Wang, X., Zhang, L., Ma, X., Zhou, J., Ju, R.-J., Li, X., Zhao, W., & Lü, W.-L. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.055 · Cited by 99 · see citing works

Molecular Targets of Arsenic Trioxide in Malignant Cells

Miller, W. H. (2002) · The Oncologist · doi:10.1634/theoncologist.7-suppl_1-14 · Cited by 94 · see citing works

Problems of glioblastoma multiforme drug resistance

Stavrovskaya, A. A., Сакенович, Ш. С., & Rybalkina, E. Y. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916020036 · Cited by 91 · see citing works

Curcumin Stimulates Reactive Oxygen Species Production and Potentiates Apoptosis Induction by the Antitumor Drugs Arsenic Trioxide and Lonidamine in Human Myeloid Leukemia Cell Lines

Sánchez, Y., Simón, G. P., Calviño, E., de Blas, E., & Aller, P. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.168344 · Cited by 88 · see citing works

Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis

Sordet, O., Rébé, C., Leroy, I., Bruey, J., Garrido, C., Miguet‐Alfonsi, C., Lizard, G., Plenchette, S., Corcos, L., & Solary, É. (2001) · Blood · doi:10.1182/blood.v97.12.3931 · Cited by 87 · see citing works

Potentiation of radiation effects on two murine tumors by lonidamine.

Kim, J. H., Alfieri, A. A., Kim, S. H., & Young, C. W. (1986) · PubMed · Cited by 85 · see citing works

Drug specific resistance to oxaliplatin is associated with apoptosis defect in a cellular model of colon carcinoma

Gourdier, I., Rio, M. D., Crabbé, L., Candeil, L., Copois, V., Ychou, M., Auffray, C., Martineau, P., Mechti, N., Pommier, Y. G., et al. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03347-1 · Cited by 83 · see citing works

Lonidamine induces intracellular tumor acidification and ATP depletion in breast, prostate and ovarian cancer xenografts and potentiates response to doxorubicin

Nath, K., NELSON, D. S., Heitjan, D. F., Leeper, D. B., Zhou, R., & Glickson, J. D. (2014) · NMR in Biomedicine · doi:10.1002/nbm.3240 · Cited by 82 · see citing works

5-ALA mediated photodynamic therapy induces autophagic cell death via AMP-activated protein kinase

Ji, H.-T., Chien, L., Lin, Y.-H., Chien, H., & Chen, C. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-91 · Cited by 79 · see citing works

Multi-responsive albumin-lonidamine conjugated hybridized gold nanoparticle as a combined photothermal-chemotherapy for synergistic tumor ablation

Ruttala, H. B., Ramasamy, T., Poudel, B. K., Ruttala, R. R. T., Jin, S. G., Choi, H., Ku, S., Yong, C. S., & Kim, J. O. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.11.003 · Cited by 78 · see citing works

Activation of Platinum(IV) Prodrugs By Motexafin Gadolinium as a Redox Mediator

Thiabaud, G., McCall, R., He, G., Arambula, J. F., Siddik, Z. H., & Sessler, J. L. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201604236 · Cited by 71 · see citing works

Preferential effects of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) on pulmonary glutathione reductase and glutathione/glutathione disulfide ratios: possible implications for lung toxicity.

Smith, A. C., & Boyd, M. R. (1984) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21862-6 · Cited by 70 · see citing works

Inhibition of the recovery from potentially lethal damage by lonidamine

Hahn, G. M., Kersen, I. V., & Silvestrini, B. (1984) · British Journal of Cancer · doi:10.1038/bjc.1984.232 · Cited by 65 · see citing works

Pharmacokinetics and toxicity of oral and intravenous lonidamine in dogs

Price, G. S., Page, R. L., Riviere, J. E., Cline, J. M., & Thrall, D. Ε. (1996) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050460 · Cited by 62 · see citing works

Targeting tumour energy metabolism potentiates the cytotoxicity of 5-aminolevulinic acid photodynamic therapy

Golding, J. P., Wardhaugh, T., Patrick, L., Turner, M., Phillips, J. B., Bruce, J. I., & Kimani, S. G. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.391 · Cited by 60 · see citing works

Combination delivery of Adjudin and Doxorubicin via integrating drug conjugation and nanocarrier approaches for the treatment of drug-resistant cancer cells

Xu, L., Gao, C., Wu, Y., Cheng, C. Y., Xia, W., & Zhang, Z. (2015) · Journal of Materials Chemistry B · doi:10.1039/c4tb01764a · Cited by 60 · see citing works

Doxorubicin and adjudin co-loaded pH-sensitive nanoparticles for the treatment of drug-resistant cancer

Wang, Q., Zou, C., Wang, L., Gao, X., Wu, J., Tan, S., & Wu, G. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.05.061 · Cited by 55 · see citing works

Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation

Calviño, E., Estañ, M. C., Simón, G. P., Sancho, P., Boyano-Adánez, M. D. C., de Blas, E., Bréard, J., & Aller, P. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.08.017 · Cited by 53 · see citing works

Effects of lonidamine alone or combined with hyperthermia in some experimental cell and tumour systems

Silvestrini, B., Hahn, G. M., Cioli, V., & Martino, C. D. (1983) · British Journal of Cancer · doi:10.1038/bjc.1983.30 · Cited by 52 · see citing works

Enhancement of doxorubicin content by the antitumor drug lonidamine in resistant ehrlich ascites tumor cells through modulation of energy metabolism

Floridi, A., Bruno, T., Miccadei, S., Fanciulli, M., Federico, A., & Paggi, M. G. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00054-9 · Cited by 51 · see citing works

Effects of combinations of azaserine and of 6-diazo-5-oxo-L-norleucine with purine analogs and other antimetabolites on the growth of two mouse mammary carcinomas.

Tarnowski, G. S., & Stock, C. (1957) · PubMed · Cited by 50 · see citing works

Mechanism of action of lonidamine in the 9L brain tumor model involves inhibition of lactate efflux and intracellular acidification

Ben‐Yoseph, O., Lyons, J. C., Song, C. W., & Ross, B. D. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1005819604858 · Cited by 50 · see citing works

31P and 1H MRS of DB‐1 melanoma xenografts: lonidamine selectively decreases tumor intracellular pH and energy status and sensitizes tumors to melphalan

Nath, K., NELSON, D. S., Ho, A. M., Lee, S., Darpolor, M. M., Pickup, S., Zhou, R., Heitjan, D. F., Leeper, D. B., & Glickson, J. D. (2012) · NMR in Biomedicine · doi:10.1002/nbm.2824 · Cited by 48 · see citing works

3-Bromopyruvate regulates the status of glycolysis and BCNU sensitivity in human hepatocellular carcinoma cells

Sun, X., Sun, G., Huang, Y., Hao, Y., Tang, X., Zhang, N., Zhao, L., Zhong, R., & Peng, Y. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113988 · Cited by 48 · see citing works

Modification of Recovery from Potentially Lethal X-Ray Damage in Plateau Phase Chinese Hamster Cells

Evans, R. G., Bagshaw, M. A., Gordon, L. F., Kurkjian, S. D., & Hahn, G. M. (1974) · Radiation Research · doi:10.2307/3574076 · Cited by 47 · see citing works

Lonidamine: A Hyperthermic Sensitizer of HeLa Cells in Culture and of the Meth-A Tumor in vivo

Kim, J. H., Kim, S. H., Alfieri, A. A., Young, C. W., & Silvestrini, B. (2009) · Oncology · doi:10.1159/000225882 · Cited by 47 · see citing works

The Specific Role of O 6 -Methylguanine-DNA Methyltransferase Inhibitors in Cancer Chemotherapy

Sun, G., Zhao, L., Zhong, R., & Peng, Y. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0069 · Cited by 47 · see citing works

The differential response of human tumours to fractionated radiation may be due to a post-irradiation repair process

Weichselbaum, R. R., & Little, J. B. (1982) · British Journal of Cancer · doi:10.1038/bjc.1982.237 · Cited by 45 · see citing works

Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG)

Kuin, A., Aalders, M. C. G., Lamfers, M. L. M., van Zuidam, D. J., Essers, M., Beijnen, J. H., & Smets, L. A. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690127 · Cited by 45 · see citing works

Reduction of Intracellular pH as a Strategy to Enhance the pH-Dependent Cytotoxic Effects of Melphalan for Human Breast Cancer Cells

Wong, P. W., Lee, C. M., & Tannock, I. F. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2472 · Cited by 44 · see citing works

A phase II clinical and pharmacokinetic study of Lonidamine in patients with advanced breast cancer

Mansi, J. L., de Graeff, A., Newell, D., Glaholm, J., Button, D., Leach, M. O., Payne, G. S., & Smith, I. E. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.356 · Cited by 44 · see citing works

Matrine Promotes Human Myeloid Leukemia Cells Apoptosis Through Warburg Effect Mediated by Hexokinase 2

Lin, G., Wu, Y., Cai, F., Li, Z., Su, S., Wang, J., Cao, J., & Ma, L. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01069 · Cited by 43 · see citing works

Lonidamine as a modulator of alkylating agent activity in vitro and in vivo.

Teicher, B. A., Herman, T. S., Holden, S. A., Epelbaum, R., Liu, S. D., & Frei, E. (1991) · PubMed · Cited by 41 · see citing works

Effect of BCNU pretreatment on diquat-induced oxidant stress and hepatotoxicity

Smith, C. V. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(87)80526-0 · Cited by 41 · see citing works

Noninvasive real-time monitoring of intracellular cancer cell metabolism and response to lonidamine treatment using diffusion weighted proton magnetic resonance spectroscopy.

Mardor, Y., Kaplan, O., Sterin, M., Ruı́z-Cabello, J., Ash, E., Roth, Y., Ringel, I., & Cohen, J. S. (2000) · PubMed · Cited by 40 · see citing works

Doxorubicin combined with betulinic acid or lonidamine in RGD ligand-targeted pH-sensitive micellar system for ovarian cancer treatment

Jin, X., Zhou, J., Zhang, Z., & Lv, H. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118751 · Cited by 39 · see citing works

FEC (5-fluorouracil, epidoxorubicin and cyclophosphamide) versus EM (epidoxorubicin and mitomycin-C) with or without lonidamine as first-line treatment for advanced breast cancer. A multicentric randomised study. Final results

Pacini, P., Rinaldini, M., Algeri, R., Guarneri, A., Tucci, E., Barsanti, G., Neri, B., Bastiani, P., Marzano, S., & Fallai, C. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00068-x · Cited by 38 · see citing works

Inhibition of matrine against gastric cancer cell line MNK45 growth and its anti-tumor mechanism

Luo, C., Zhong, H., Zhu, L., Wu, X. G., Ying, J., Wang, X., LÜ, W. X., Xu, Q., Zhu, Y., & Huang, J. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1346-5 · Cited by 38 · see citing works

Effective platinum(IV) prodrugs conjugated with lonidamine as a functional group working on the mitochondria

Chen, H., Chen, F., Hu, W., & Gou, S. (2017) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2017.11.017 · Cited by 38 · see citing works

Male contraceptive Adjudin is a potential anti-cancer drug

Xie, Q. R., Liu, Y., Shao, J., Yang, J., Liu, T., Zhang, T., Wang, B., Mruk, D. D., Silvestrini, B., Cheng, C. Y., et al. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.11.008 · Cited by 34 · see citing works

A Linear-RBF Multikernel SVM to Classify Big Text Corpora

Romero, R., Iglesias, E. L., & Borrajo, L. (2015) · BioMed Research International · doi:10.1155/2015/878291 · Cited by 33 · see citing works

Stimulation of the apoptotic response as a basis for the therapeutic synergism of lonidamine and cisplatin in combination in human tumour xenografts

Cesare, M. D., Pratesi, G., Giusti, A., Polizzi, D., & Zunino, F. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.69 · Cited by 32 · see citing works

The Rediscovery of DON (6-Diazo-5-oxo-L-norleucine)

Kisner, D. L., Catane, R., & Muggia, F. M. (1980) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-81488-4_30 · Cited by 31 · see citing works

Matrine suppresses cell growth of human chronic myeloid leukemia cells via its inhibition of the interleukin-6/Janus activated kinase/signal transducer and activator of transcription 3 signaling cohort

Ma, L., Zhu, Z., Jiang, L., Sun, X. Y., Lu, X., Zhou, M., Qian, S., & Li, J. (2015) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2015.1007507 · Cited by 31 · see citing works

The novel platinum(IV) prodrug with self-assembly property and structure-transformable character against triple-negative breast cancer

Yang, C., Tu, K., Gao, H., Zhang, L., Sun, Y., Yang, T., Kong, L., Ouyang, D., & Zhang, Z. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119751 · Cited by 31 · see citing works

Antitumor effects of a drug combination targeting glycolysis, glutaminolysis and de novo synthesis of fatty acids

Cervantes-Madrid, D., & Dueñas‐González, A. (2015) · Oncology Reports · doi:10.3892/or.2015.4077 · Cited by 30 · see citing works

The role of glutamine and glucose analogues in metabolic inhibition of human myeloid leukaemia In vitro

Griffiths, M., Keast, D. H., Crawford, M. A., Palmer, T. N., & Patrick, G. J. (1993) · International Journal of Biochemistry · doi:10.1016/0020-711x(88)90303-5 · Cited by 30 · see citing works

Feasibility and antitumor efficacy in vivo, of simultaneously targeting glycolysis, glutaminolysis and fatty acid synthesis using lonidamine, 6-diazo-5-oxo-L-norleucine and orlistat in colon cancer

Cervantes-Madrid, D., Domínguez-Gómez, G., González‐Fierro, A., Pérez‐Cárdenas, E., Taja‐Chayeb, L., Trejo‐Becerril, C., & Dueñas‐González, A. (2017) · Oncology Letters · doi:10.3892/ol.2017.5615 · Cited by 30 · see citing works

The energy blockers bromopyruvate and lonidamine lead GL15 glioblastoma cells to death by different p53-dependent routes

Davidescu, M., Macchioni, L., Scaramozzino, G., Marchetti, M. C., Migliorati, G., Vitale, R., Corcelli, A., Roberti, R., Castigli, E., & Corazzi, L. (2015) · Scientific Reports · doi:10.1038/srep14343 · Cited by 29 · see citing works

Changes of Energy Metabolism in the Germ Cells and Ehrlich Ascites Tumor Cells

Floridi, A., BELLOCCI, M., Paggi, M. G., Marcante, M. L., & Martino, C. D. (2009) · Chemotherapy · doi:10.1159/000238045 · Cited by 28 · see citing works

The Potential of Combi-Molecules with DNA-Damaging Function as Anticancer Agents

Sun, G., Fan, T., Zhao, L., Zhou, Y., & Zhong, R. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0229 · Cited by 28 · see citing works

Phase II study of lonidamine in patients with metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group Study.

Band, P. R., Maroun, J., Pritchard, K. I., Stewart, D. E., Coppin, C., Wilson, K., & Eisenhauer, E. A. (1986) · PubMed · Cited by 27 · see citing works

Effect of lonidamine on the utilization of 14C-labeled glucose by human astrocytoma cells

Paggi, M. G., Zupi, G., Fanciulli, M., Carlo, C. D., Giorno, S., Laudonio, N., Silvestrini, B., Caputo, A., & Floridi, A. (1987) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(87)90070-0 · Cited by 26 · see citing works

Matrine promotes G0/G1 arrest and down-regulates cyclin D1 expression in human rhabdomyosarcoma cells.

Guo, L. M., Xue, T.-Y., Xu, W., & Gao, J.-Z. (2013) · PubMed · Cited by 26 · see citing works

The Induction and Repair of DNA Interstrand Crosslinks and Implications in Cancer Chemotherapy

Guohui, S., Lijiao, Z., & Ru-gang, Z. (2015) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520615666150824160421 · Cited by 25 · see citing works

An enzyme-assisted self-delivery system of lonidamine–peptide conjugates for selectively killing cancer cells

Wu, C., Liu, J., Tang, X., Zhai, Z., Xu, K., & Zhong, W. (2019) · Chemical Communications · doi:10.1039/c9cc06204a · Cited by 23 · see citing works

Effects of the inhibitors of energy metabolism, lonidamine and levamisole, on 5-aminolevulinic-acid-induced photochemotherapy

Shevchuk, I. N., Chekulayev, V. A., Moan, J. E., & Berg, K. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960917)67:6 · Cited by 22 · see citing works

Phase I Toxicologic Study of Lonidamine in Cancer Patients

Band, P. R., Deschamps, M., Besner, J., Leclaire, R., Gervais, P., & Sanctis, A. D. (2009) · Oncology · doi:10.1159/000225887 · Cited by 22 · see citing works

Glycolytic inhibition by 3-bromopyruvate increases the cytotoxic effects of chloroethylnitrosoureas to human glioma cells and the DNA interstrand cross-links formation

Sun, X., Sun, G., Huang, Y., Zhang, S., Tang, X., Zhang, N., Zhao, L., Zhong, R., & Peng, Y. (2020) · Toxicology · doi:10.1016/j.tox.2020.152413 · Cited by 22 · see citing works

Effects of hyperglycemia on lonidamine‐induced acidification and de‐energization of human melanoma xenografts and sensitization to melphalan

Nath, K., NELSON, D. S., Heitjan, D. F., Zhou, R., Leeper, D. B., & Glickson, J. D. (2015) · NMR in Biomedicine · doi:10.1002/nbm.3260 · Cited by 20 · see citing works

Aplastic Anemia as a Cause of Death in a Patient with Glioblastoma Multiforme Treated with Temozolomide

Kopecký, J., Priester, P., Slováček, L., Petera, J., Kopecký, O., & Macingova, Z. (2010) · Strahlentherapie und Onkologie · doi:10.1007/s00066-010-2132-3 · Cited by 20 · see citing works

Lonidamine: a non-mutagenic antitumor agent

Forster, R. P., Campana, A., D’Onofrio, E., Henderson, L., Mosesso, P., & Barcellona, P. S. (1990) · Carcinogenesis · doi:10.1093/carcin/11.9.1509 · Cited by 20 · see citing works

Micelle System Based on Molecular Economy Principle for Overcoming Multidrug Resistance and Inhibiting Metastasis

Qi, Y., Qin, X., Yang, C., Wu, T., Qiao, Q., Song, Q., & Zhang, Z. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00922 · Cited by 19 · see citing works

Cytotoxicity of lonidamine alone and in combination with other drugs against murine RIF-1 and human HT1080 cells in vitro.

Ning, S. C., & Hahn, G. M. (1990) · PubMed · Cited by 18 · see citing works

How Mainstream Medicine Sees Photodynamic Therapy in the United Kingdom

Bown, S. G. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0180 · Cited by 18 · see citing works

A prospective randomized comparison of radiation therapy plus lonidamine versus radiation therapy plus placebo as initial treatment of clinically localized but nonresectable nonsmall cell lung cancer

Scarantino, C. W., McCunniff, A. J., Evans, G., Young, C. W., & Paggiarino, D. A. (1994) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)90394-8 · Cited by 17 · see citing works

In vitro potentiation by lonidamine of the cytotoxic effect of adriamycin on primary and established breast cancer cell lines

Savini, S., Zoli, W., Nanni, O., Volpi, A., Frassineti, G. L., Magni, E., Flamigni, A., Amadori, A., & Amadori, D. (1992) · Breast Cancer Research and Treatment · doi:10.1007/bf01832355 · Cited by 17 · see citing works

Combination therapy: lonidamine, hyperthermia, and chemotherapy against the RIF-1 tumor in vivo.

Ning, S. C., & Hahn, G. M. (1991) · PubMed · Cited by 15 · see citing works

Potentiation of radiation effects on multicellular tumor spheroids (mts) of hela cells by lonidamine

Kim, J. H., Kim, S. H., He, S.-Q., Alfieri, A. A., & Young, C. W. (1989) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(89)90298-8 · Cited by 14 · see citing works

Weekly epirubicin plus lonidamine in advanced breast carcinoma

Nisticò, C., Garufi, C., Milella, M., D'Ottavio, A. M., Vaccaro, A., Fabi, A., & Terzoli, E. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006213815195 · Cited by 14 · see citing works

Effect of Lonidamine on Systemic Therapy of DB-1 Human Melanoma Xenografts with Temozolomide

Nath, K., NELSON, D. S., Roman, J., Putt, M. E., Lee, S., Leeper, D. B., & Glickson, J. D. (2017) · Anticancer Research · doi:10.21873/anticanres.11708 · Cited by 14 · see citing works

Effect of Differences in Metabolic Activity of Melanoma Models on Response to Lonidamine plus Doxorubicin

Nath, K., Roman, J., NELSON, D. S., Guo, L., Lee, S., Orlovskiy, S., Muriuki, K., Heitjan, D. F., Pickup, S., Leeper, D. B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-33019-4 · Cited by 13 · see citing works

Enhancement of sensitivity to hyperthermia by Lonidamine in human cancer cells

Raaphorst, G. P., Feeley, M., Martin, L., Danjoux, C. E., Maroun, J., Desanctis, A. J., & Ko, D. (1991) · International Journal of Hyperthermia · doi:10.3109/02656739109056445 · Cited by 12 · see citing works

Thermal sensitisation by lonidamine of human melanoma cells grown at low extracellular pH

Coss, R. A., Storck, C., Wells, T. C., Kulp, K. A., Wahl, M., & Leeper, D. B. (2013) · International Journal of Hyperthermia · doi:10.3109/02656736.2013.858832 · Cited by 11 · see citing works

The Blepharis persica seed hydroalcoholic extract synergistically enhances the apoptotic effect of doxorubicin in human colon cancer and gastric cancer cells

Aghaabbasi, K., Askari, N., Kumleh, H. H., Torkzadeh‐Mahani, M., & Ghara, A. R. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04711-z · Cited by 11 · see citing works

Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice

Nath, K., NELSON, D. S., Putt, M. E., Leeper, D. B., Garman, B., Nathanson, K. L., & Glickson, J. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157125 · Cited by 10 · see citing works

Enhancement of hyperthermic toxicity by lonidarnine in the dunning R3327G rat prostatic adenocarcinoma

Bloch, W. E., Lokeshwar, B. L., FERRELL, S. M., & Block, N. L. (1994) · The Prostate · doi:10.1002/pros.2990240306 · Cited by 9 · see citing works

Effect of daunorubicin on acute promyelocytic leukemia cells using nuclear magnetic resonance spectroscopy-based metabolomics

Nong, Q., Zhang, C., Liu, Q., Xie, R., & Dong, M. (2020) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2020.103382 · Cited by 6 · see citing works

Targeting monocarboxylate transporters (MCTs) in cancer: How close are we to the clinics?

Singh, M., Afonso, J., Sharma, D., Gupta, R., Kumar, V., Rani, R., Baltazar, F., & Kumar, V. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.01.007 · Cited by 189 · see citing works

Dysregulation of metabolic pathways in pulmonary fibrosis

Rajesh, R., Atallah, R., & Bärnthaler, T. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108436 · Cited by 127 · see citing works

The Warburg effect: a score for many instruments in the concert of cancer and cancer niche cells

Jaworska, M., Szczudło, J., Pietrzyk, A., Shah, J., Trojan, S., Ostrowska, B., & Kocemba‐Pilarczyk, K. A. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00504-1 · Cited by 120 · see citing works

Mitochondria-Targeted Multifunctional Nanoprodrugs by Inhibiting Metabolic Reprogramming for Combating Cisplatin-Resistant Lung Cancer

Lu, H., Tong, W., Jiang, M., Liu, H., Meng, C., Wang, K., & Mu, X. (2024) · ACS Nano · doi:10.1021/acsnano.4c04024 · Cited by 92 · see citing works

Nanomaterial-enabled metabolic reprogramming strategies for boosting antitumor immunity

Ma, M., Zhang, Y., Pu, K., & Tang, W. (2024) · Chemical Society Reviews · doi:10.1039/d4cs00679h · Cited by 97 · see citing works

GLUT and HK: Two primary and essential key players in tumor glycolysis

Yadav, D., Yadav, A., Bhattacharya, S., Dagar, A., Kumar, V., & Rani, R. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.03.001 · Cited by 87 · see citing works

Antibody-conjugated liposomes loaded with indocyanine green for oral targeted photoacoustic imaging-guided sonodynamic therapy of Helicobacter pylori infection

Wang, R., Song, C., Gao, A., Liu, Q., Guan, W., Mei, J., Ma, L., & Cui, D. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.02.031 · Cited by 77 · see citing works

Biomimetic nanoparticles for effective mild temperature photothermal therapy and multimodal imaging

Shu, X., Chen, Y., Yan, P., Xiang, Y., Shi, Q., Yin, T., Wang, P., Liu, L., & Shuai, X. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.05.010 · Cited by 69 · see citing works

Targeting lactate metabolism and glycolytic pathways in the tumor microenvironment by natural products: A promising strategy in combating cancer

Kooshki, L., Mahdavi, P., Fakhri, S., Akkol, E. K., & Khan, H. Z. (2021) · BioFactors · doi:10.1002/biof.1799 · Cited by 67 · see citing works

Cyanine dyes in the mitochondria-targeting photodynamic and photothermal therapy

Kejík, Z., Hajduch, J., Abramenko, N., Vellieux, F. M. D., Veselá, K., Fialová, J. L., Petrláková, K., Kučnirová, K., Kaplánek, R., Tatar, A., et al. (2024) · Communications Chemistry · doi:10.1038/s42004-024-01256-6 · Cited by 68 · see citing works

Metabolic Intervention Liposome Boosted Lung Cancer Radio‐Immunotherapy via Hypoxia Amelioration and PD‐L1 Restraint

Wang, S., Zhou, Z., Hu, R., Dong, M., Zhou, X., Ren, S.-Y., Zhang, Y., Chen, C., Huang, R., Zhu, M., et al. (2023) · Advanced Science · doi:10.1002/advs.202207608 · Cited by 66 · see citing works

Linking Metabolic Reprogramming, Plasticity and Tumor Progression

Shuvalov, O., Daks, A., Fedorova, O., Petukhov, A., & Barlev, N. (2021) · Cancers · doi:10.3390/cancers13040762 · Cited by 63 · see citing works

The mitochondrial pyruvate carrier at the crossroads of intermediary metabolism

Yiew, N. K. H., & Finck, B. N. (2022) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00074.2022 · Cited by 63 · see citing works

Contemporary Perspectives on the Warburg Effect Inhibition in Cancer Therapy

Kozal, K., Jóźwiak, P., & Krześlak, A. (2021) · Cancer Control · doi:10.1177/10732748211041243 · Cited by 63 · see citing works

Functions and mechanisms of lactylation in carcinogenesis and immunosuppression

Su, J., Zheng, Z., Bian, C., Chang, S., Bao, J., Yu, H., Xin, Y., & Jiang, X. M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1253064 · Cited by 57 · see citing works

Transcriptional regulation and post-translational modifications in the glycolytic pathway for targeted cancer therapy

Ni, X., Lu, C., Xu, G.-Q., & Ma, J. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01264-1 · Cited by 56 · see citing works

Amplification of anticancer efficacy by co-delivery of doxorubicin and lonidamine with extracellular vesicles

Li, H., Xu, W., Li, F., Zeng, R., Zhang, X., Wang, X., Zhao, S., Weng, J., Zhu, L., & Sun, L. (2022) · Drug Delivery · doi:10.1080/10717544.2021.2023697 · Cited by 54 · see citing works

Therapeutic targeting of immunometabolism reveals a critical reliance on hexokinase 2 dosage for microglial activation and Alzheimer’s progression

Codocedo, J. F., Mera-Reina, C., Bor-Chian Lin, P., Fallen, P. B., Puntambekar, S. S., Casali, B. T., Jury-Garfe, N., Martinez, P., Lasagna-Reeves, C. A., & Landreth, G. E. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114488 · Cited by 52 · see citing works

Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics

Pal, S., Sharma, A. K., Mathew, S. P., & Jaganathan, B. G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.955476 · Cited by 49 · see citing works

Lactate-related metabolic reprogramming and immune regulation in colorectal cancer

Sun, Q., Wu, J., Zhu, G., Li, T., Zhu, X., Ni, B., Xu, B., Ma, X., & Li, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1089918 · Cited by 45 · see citing works

Fifty years of the mitochondrial pyruvate carrier: New insights into its structure, function, and inhibition

Tavoulari, S., Sichrovsky, M., & Kunji, E. R. S. (2023) · Acta Physiologica · doi:10.1111/apha.14016 · Cited by 43 · see citing works

Role of Glucose Metabolic Reprogramming in Breast Cancer Progression and Drug Resistance

Lei, P., Wang, W., Sheldon, M., Sun, Y., Yao, F., & Ma, L. (2023) · Cancers · doi:10.3390/cancers15133390 · Cited by 40 · see citing works

Endogenous Zinc‐Ion‐Triggered In Situ Gelation Enables Zn Capture to Reprogram Benign Hyperplastic Prostate Microenvironment and Shrink Prostate

Ge, J., Fang, C., Tan, H., Zhan, M., Gu, M., Ni, J., Yang, G., Zhang, H., Ni, J., Zhang, K., et al. (2023) · Advanced Materials · doi:10.1002/adma.202307796 · Cited by 39 · see citing works

Exploring the mystery of tumor metabolism: Warburg effect and mitochondrial metabolism fighting side by side

Yu, Y., Jiang, Y., Glandorff, C., & Sun, M. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111239 · Cited by 39 · see citing works

Innovations in Cancer Therapy: Endogenous Stimuli-Responsive Liposomes as Advanced Nanocarriers

Torres, J., Oses, J. K. V., Rabasco, A. M., González-Rodrı́guez, M. L., & García, M. C. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17020245 · Cited by 40 · see citing works

Inhibiting Glycolysis and Disrupting the Mitochondrial HK2–VDAC1 Protein–Protein Interaction Using a Bifunctional Lonidamine-Conjugated Metal Probe for Combating Triple-Negative Breast Cancer

Wang, L., Kong, L., Zhang, D., Ye, L., Nao, S.-C., Chan, D. S., Li, X., Peng, Y., Yang, L., Wong, C.-Y., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c04233 · Cited by 39 · see citing works

2-Deoxy-D-glucose increases the sensitivity of glioblastoma cells to BCNU through the regulation of glycolysis, ROS and ERS pathways: In vitro and in vivo validation

Sun, X., Fan, T., Sun, G., Zhou, Y., Huang, Y., Zhang, N., Zhao, L., Zhong, R., & Peng, Y. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115029 · Cited by 39 · see citing works

Hexokinase 2 confers radio-resistance in hepatocellular carcinoma by promoting autophagy-dependent degradation of AIMP2

Zheng, Y., Zhan, Y., Zhang, Y., Zhang, Y., Liu, Y., Xie, Y., Sun, Y., Qian, J., Ding, Y., Ding, Y., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06009-2 · Cited by 37 · see citing works

Glutathione‐Sensitive Photosensitizer–Drug Conjugates Target the Mitochondria to Overcome Multi‐Drug Resistance in Cancer

Song, W., Yang, H., Wang, Y., Chen, S., Zhong, W., Wang, Q., Ding, W., Xu, G., Chen, M., Liang, Y., et al. (2024) · Advanced Science · doi:10.1002/advs.202307765 · Cited by 36 · see citing works

Active mitochondrial respiration in cancer: a target for the drug

Bedi, M., Ray, M., & Ghosh, A. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04281-4 · Cited by 34 · see citing works

Tumor energy metabolism: implications for therapeutic targets

Hu, Y., Liu, W., Fang, W., Dong, Y., Zhang, H., & Luo, Q. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00229-4 · Cited by 32 · see citing works

The Molecular Mechanisms behind Advanced Breast Cancer Metabolism: Warburg Effect, OXPHOS, and Calcium

Mitaishvili, E., Feinsod, H., David, Z., Shpigel, J., Fernandez, C., Sauane, M., & de la Parra, C. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2903099 · Cited by 31 · see citing works

Multimodal representation learning for predicting molecule–disease relations

Wen, J., Zhang, X., Rush, E. N., Panickan, V. A., Li, X., Cai, T. A., Ho, Y.-L. A., Ho, Y.-L., Costa, L., Begoli, E., et al. (2023) · Bioinformatics · doi:10.1093/bioinformatics/btad085 · Cited by 28 · see citing works

Podophyllotoxin: Recent Advances in the Development of Hybridization Strategies to Enhance Its Antitumoral Profile

Miranda‐Vera, C., Hernández, Á., Garcı́a, P. G., David Diez, A., García, P. A., & Castro, M. A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15122728 · Cited by 27 · see citing works

Antineoplastic Properties by Proapoptotic Mechanisms Induction of Inula viscosa and Its Sesquiterpene Lactones Tomentosin and Inuviscolide

Migheli, R., Virdis, P., Galleri, G., Arru, C., Lostia, G., Coradduzza, D., Muroni, M. R., Pintore, G., Podda, L., Fozza, C., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10112739 · Cited by 25 · see citing works

Research progress of hyperthermia in tumor therapy by influencing metabolic reprogramming of tumor cells

Yang, Y., Huangfu, L., Li, H., & Yang, D. (2023) · International Journal of Hyperthermia · doi:10.1080/02656736.2023.2270654 · Cited by 23 · see citing works

Exploring monocarboxylate transporter inhibition for cancer treatment

Koltai, T., & Fliegel, L. (2024) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2024.00210 · Cited by 25 · see citing works

The Promoting Role of HK II in Tumor Development and the Research Progress of Its Inhibitors

Liu, B., Lu, Y., Taledaohan, A., Qiao, S., Li, Q., & Wang, Y. (2023) · Molecules · doi:10.3390/molecules29010075 · Cited by 24 · see citing works

20-Hydroxyecdysone Confers Antioxidant and Antineoplastic Properties in Human Non-Small Cell Lung Cancer Cells

Shuvalov, O., Kirdeeva, Y., Fefilova, E., Netsvetay, S., Zorin, M., Vlasova, Y., Fedorova, O., Daks, A., Parfenyev, S., & Barlev, N. (2023) · Metabolites · doi:10.3390/metabo13050656 · Cited by 21 · see citing works

Co-delivery of mitochondrial targeted lonidamine and PIN1 inhibitor ATRA by nanoparticulate systems for synergistic metastasis suppression

Chen, C., Li, Q., Xing, L., Zhou, M., Luo, C., Li, S., Li, L., & Huang, Y. (2021) · Nano Research · doi:10.1007/s12274-021-3923-9 · Cited by 21 · see citing works

cRGD-modified nanoparticles of multi-bioactive agent conjugate with pH-sensitive linkers and PD-L1 antagonist for integrative collaborative treatment of breast cancer

Zou, C., Tang, Y., Zeng, P., Cui, D., Amili, M. A., Chang, Y. F., Zhu, J., Shen, Y., Tan, S., & Guo, S. (2023) · Nanoscale Horizons · doi:10.1039/d2nh00590e · Cited by 20 · see citing works

Role of monocarboxylate transporters in cancer immunology and their therapeutic potential

Faghihkhorasani, F., Moosavi, M., Abdulwahid, A. R. R., Kavei, M., Karimi, S., Karimi, M. S., Vezvaei, P., Varkiani, M. M., Aref, A. R., & Ebrahimi, N. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70110 · Cited by 18 · see citing works

Dendrimer-Entrapped CuPt Bimetallic Nanozymes for Tumor Microenvironment-Regulated Photothermal/Catalytic Therapy

Lu, S., Li, A., Huang, H., Ni, C., Cao, X., Shi, X., & Guo, R. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c05324 · Cited by 17 · see citing works

Mitochondrial Targeting and pH-Responsive Nanogels for Co-Delivery of Lonidamine and Paclitaxel to Conquer Drug Resistance

Chen, E., Wang, T., Zhang, J., Zhou, X. Y., Niu, Y., Liu, F., Zhong, Y., Huang, D., & Chen, W. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.787320 · Cited by 17 · see citing works

Salvia miltiorrhiza inhibited lung cancer through aerobic glycolysis suppression

Bai, J., Qin, Q., Li, S., Cui, X., Zhong, Y., Yang, L., An, L., Deng, D., Zhao, J., Zhang, R., et al. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118281 · Cited by 17 · see citing works

Flipping the Switch: MeCP2‐Mediated Lactylation Rewires Microglial Metabolism and Inflammation via the HK2/mTOR Axis in Poststroke Neuroinflammation

Zhang, Z., Huang, S., Wang, Y., Jiang, Z., Liu, Z., Wang, C., Ji, R., Yuan, Y., Mao, X., Yang, K., et al. (2025) · Advanced Science · doi:10.1002/advs.202513400 · Cited by 16 · see citing works

A mitochondria-targeting self-assembled carrier-free lonidamine nanodrug for redox-activated drug release to enhance cancer chemotherapy

Yang, T., Zhang, X., Yang, X., Li, Y., Xiang, J., Xiang, C., Liu, Z., Hai, L., Huang, S., Zhou, L., et al. (2023) · Journal of Materials Chemistry B · doi:10.1039/d2tb02728c · Cited by 16 · see citing works

Progress in the treatment of drug-loaded nanomaterials in renal cell carcinoma

Li, J., Wu, K.-Z., Zhang, J., Gao, H., & Xu, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115444 · Cited by 16 · see citing works

Aptamer‐modified tetrahedral DNA nanostructure‐immobilized liposome for specific gene delivery and potential cancer theragnostic

Lim, D. Y., & Hwang, B. H. (2023) · Biotechnology Journal · doi:10.1002/biot.202300156 · Cited by 16 · see citing works

[Role and Mechanism of Lactylation in Cancer].

Zhang, Q., Cao, L., & Xu, K. (2024) · PubMed Central · doi:10.3779/j.issn.1009-3419.2024.102.20 · Cited by 15 · see citing works

Photothermal therapy enhance the anti-mitochondrial metabolism effect of lonidamine to renal cell carcinoma in homologous-targeted nanosystem

Chen, J., Ren, F., Cao, W., Wu, Z., Ju, G., Xiao, C., Wu, W., Gao, S., Xu, C., & Gao, Y. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2021.102370 · Cited by 15 · see citing works

Energy Blocker Lonidamine Reverses Nimustine Resistance in Human Glioblastoma Cells through Energy Blockade, Redox Homeostasis Disruption, and O 6 -Methylguanine-DNA Methyltransferase Downregulation: In Vitro and In Vivo Validation

Huang, Y., Wang, P., Fan, T., Zhang, N., Zhao, L., Zhong, R., & Sun, G. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00085 · Cited by 14 · see citing works

Synthesis of Novel Hybrid Lonidamine-Coumarin Derivatives and Their Anticancer Activities

İpek, Ö. Ş., Sucu, B. O., Gül, Ş., Yolaçan, Ç., & Güzel, M. (2023) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2023.135114 · Cited by 14 · see citing works

Targeting lactate metabolism in the tumor microenvironment: Immunomodulation and prospects for antitumor therapy

Yan, J., Qi, Y., Liu, Y., Jiang, X., Li, Y., Song, Z., Zhang, L., & Zhang, Z. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115390 · Cited by 12 · see citing works

Targeted degradation of hexokinase 2 by a novel engineered bispecific chimeric liposome-based Nano-PROTACs for enhancing tumor chemotherapy

Gong, L., Li, S., Sun, J., Liu, R., Wang, J., Wang, S., Zhao, Y., Yan, L., Ji, M., Yang, D., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123651 · Cited by 12 · see citing works

Discovery of a novel Wnt inhibitor DK419: Reversing temozolomide resistance in glioblastoma by switching off Wnt/β-catenin signaling pathway to inhibit MGMT expression

Bai, P., Wang, P., Ren, T., Tang, Q., Zhang, N., Zhao, L., 钟儒刚, & Sun, G. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117411 · Cited by 12 · see citing works

Addressing artifacts of colorimetric anticancer assays for plant-based drug development

Batool, S., Javaid, S., Javed, H., Asim, L., Shahid, I., Khan, M., & Muhammad, A. (2022) · Medical Oncology · doi:10.1007/s12032-022-01791-z · Cited by 12 · see citing works

Metabolic Rewiring in Cancer: Small Molecule Inhibitors in Colorectal Cancer Therapy

Masci, D., Puxeddu, M., Silvestri, R., & Regina, G. L. (2024) · Molecules · doi:10.3390/molecules29092110 · Cited by 11 · see citing works

Protective Effect of Aquilaria crassna Leaf Extract against Benzo[a]pyrene-Induced Toxicity in Neuronal Cells and Caenorhabditis elegans: Possible Active Constituent Includes Clionasterol

Pattarachotanant, N., Rangsinth, P., Warayanon, W., Leung, G., Chuchawankul, S., Prasansuklab, A., & Tencomnao, T. (2023) · Nutrients · doi:10.3390/nu15183985 · Cited by 11 · see citing works

Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines

García‐Molina, P., Sola‐Leyva, A., Luque-Navarro, P. M., Laso, A., Ríos‐Marco, P., Ríos, A., Lanari, D., Torretta, A., Parisini, E., Lopez-Cara, L. C., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020426 · Cited by 11 · see citing works

New Organometallic Ru(II) Compounds with Lonidamine Motif as Antitumor Agents

Shutkov, I. A., Okulova, Y. N., Mazur, D. M., Melnichuk, N. A., Babkov, D. A., Sokolova, E. V., Спасов, А. А., Milaeva, E. R., & Nazarov, A. A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051366 · Cited by 10 · see citing works

Bioenergetic alteration in gastrointestinal cancers: The good, the bad and the ugly

Chu, Y., Chen, C.-W. D., Lai, M., Lim, S., & Lin, W.-R. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i29.4499 · Cited by 11 · see citing works

Advances in the Study of Liposomes Gel with Stimulus Responsiveness in Disease Treatment

Yang, Q., Luo, S., Tong, S., Zhao, H., Chen, R., Song, B., & Wu, J. (2023) · Journal of Cluster Science · doi:10.1007/s10876-023-02510-y · Cited by 9 · see citing works

RNA-Seq Technology Reveals the Mechanism of SDT Combined With Novel Nanobubbles Against HCC

Shang, H., Chen, Y., Wang, C., Zhang, S., Wu, B., Liang, X., Liu, Z., Wang, Q., & Cheng, W. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.791331 · Cited by 9 · see citing works

mTORC1/rpS6 and p-FAK-Y407 signaling regulate spermatogenesis: Insights from studies of the adjudin pharmaceutical/toxicant model

Wang, L., Li, L., Wu, X., Wong, C. K. C., Perrotta, A. M., Silvestrini, B., Sun, F., & Cheng, C. Y. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.03.024 · Cited by 9 · see citing works

Is antitumor Pt(IV) complex containing two axial lonidamine ligands a true dual- or multi-action prodrug?

Kašpárková, J., Kostrhunová, H., Novohradský, V., Ma, L., Zhu, G., Milaeva, E. R., Shtill, A. A., Vinck, R., Gasser, G., Brabec, V., et al. (2022) · Metallomics · doi:10.1093/mtomcs/mfac048 · Cited by 9 · see citing works

Tumoral oxygenation and biodistribution of Lonidamine oxygen microbubbles following localized ultrasound-triggered delivery

Lacerda, Q., Rochani, A., Oeffinger, B. E., Liu, J., Wessner, C. E., Tahmasebi, A., Falatah, H. A., Lee, P., Leeper, D. B., Forsberg, F., et al. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122072 · Cited by 9 · see citing works

Development of a Dual Drug-Loaded, Surfactant-Stabilized Contrast Agent Containing Oxygen

Patel, R. B., Lacerda, Q., Oeffinger, B. E., Eisenbrey, J. R., Rochani, A., Kaushal, G., Wessner, C. E., & Wheatley, M. A. (2022) · Polymers · doi:10.3390/polym14081568 · Cited by 8 · see citing works

Glucose metabolism reprogramming in gastric cancer: Implications for tumor

Li, X., Cao, X., Wang, Y., Deng, Y., Thomas, E. R., Xiao, W., Wang, W., Xu, L., & He, Q. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115630 · Cited by 7 · see citing works

Harnessing Drug Repurposing to Combat Breast Cancer by Targeting Altered Metabolism and Epithelial-to-Mesenchymal Transition Pathways

Kandasamy, T., Sarkar, S., & Ghosh, S. S. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00545 · Cited by 7 · see citing works

Strategies for the treatment of breast cancer: from classical drugs to mathematical models

Costa, A., & Vale, N. (2021) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2021316 · Cited by 6 · see citing works

Mito-LND and (E)-Akt inhibitor-IV: novel compounds inducing endoplasmic reticulum stress and ROS accumulation against hepatocellular carcinoma

Liao, S., Wang, Q., Chen, S., Huang, Q., Zhou, L., Liu, H., He, S., & Zhou, Z. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05545-5 · Cited by 6 · see citing works

Deciphering Medulloblastoma: Epigenetic and Metabolic Changes Driving Tumorigenesis and Treatment Outcomes

Bonifacio-Mundaca, J., Casavilca-Zambrano, S. A., Desterke, C., Casafont, Í., & Mata-Garrido, J. (2025) · Biomedicines · doi:10.3390/biomedicines13081898 · Cited by 6 · see citing works

Targeted nanomedicines for the treatment of Helicobacter pylori infection

Wang, S., Ding, H., Li, L., Zhao, R., & Chai, N. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101820 · Cited by 7 · see citing works

Chemotherapy Resistance in Cancer: Mechanism and Roadmap to Evade Exploring Apoptosis

Halder, K. (2024) · International Journal of Advancement in Life Sciences Research · doi:10.31632/ijalsr.2024.v07i02.003 · Cited by 5 · see citing works

Water soluble 1,2,3-triazole based metal-free, zinc(II) and indium(III) phthalocyanines: Synthesis, characterization, photochemical and photophysical properties

Ouis, T., Khezami, K., Durmuş, M., & Saïdi‐Besbes, S. (2025) · Journal of Photochemistry and Photobiology A Chemistry · doi:10.1016/j.jphotochem.2025.116575 · Cited by 5 · see citing works

Co-delivery of copper chelators and glycolytic inhibitors to disrupt glucose metabolism and inhibit tumor metastasis

Lu, J., Feng, S., Liu, Z., Xiao, Y., Zhang, H., Wang, S., & Zhao, Q. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.165899 · Cited by 5 · see citing works

Therapeutic targeting of immunometabolism in Alzheimer’s disease reveals a critical reliance on Hexokinase 2 dosage on microglial activation and disease progressionPreprint

Codocedo, J. F., Mera-Reina, C., Lin, P. B., Puntambekar, S. S., Casali, B. T., Jury, N., Martínez, P., Lasagna‐Reeves, C. A., & Landreth, G. E. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.11.566270 · Cited by 5 · see citing works

Efficient identification of new small molecules targeting succinate dehydrogenase in non-small cell lung cancer

Silva, L. F. O., Skiados, N. G., Murugavel, N., Cover, K., Luna, N., Gupta, M., Contreras, S. C., O’Brien, T. E., & Zhang, W. C. (2025) · Cancer Cell International · doi:10.1186/s12935-025-04002-7 · Cited by 4 · see citing works

Lonidamine-1,3,4-oxadiazole derivatives with antiproliferative effects on HCT116 colon cancer cell lines: biological evaluation, ADMET, and computational studies

Bhat, R. M., Priyadarshini, A. N., Srinivasa, S. M., Muddapur, G. V., Alhussieni, K., Raman Kumar, K., & Keri, R. S. (2026) · RSC Advances · doi:10.1039/d5ra07852k · Cited by 4 · see citing works

Lonidamine, a Novel Modulator for the BvgAS System of Bordetella Species

Ota, N., Nishida, T., Standley, D. M., Sherif, A., Iwano, S., Nugraha, D. K., Ueno, T., & Horiguchi, Y. (2024) · Microbiology and Immunology · doi:10.1111/1348-0421.13193 · Cited by 4 · see citing works

Leveraging selection for function in tumor evolution: System-level cancer therapies

Frédéric Thomas, A., Capp, J., Dujon, A. M., Marusyk, A., Asselin, K., Campone, M., Pujol, P., Alix‐Panabières, C., Roche, B., Újvári, B., et al. (2025) · Evolution Medicine and Public Health · doi:10.1093/emph/eoaf022 · Cited by 4 · see citing works

Strategies for Attenuating Chemotherapy Side Effects: A Review

Almukram, A. M. A., Al-Mamoori, F. F., Sameer, H. N., Farhan, D. M., Al-Shammari, A. H., Al-Hussaniy, H. A., & Oraibi, A. I. (2024) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2024.00857 · Cited by 4 · see citing works

Carbohydrate kinase inhibition: a promising strategy in cancer treatment

Jain, A., Das, R., Giri, M., Mane, P., & Shard, A. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104308 · Cited by 4 · see citing works

Study on the Mechanism of Action of the Pt(IV) Complex with Lonidamine Ligands by Ultrafast Chemical Proteomics

Imaikina, E. A., Fedorov, I. I., Emekeeva, D. D., Kazakova, E. M., Garibova, L. A., Ivanov, M. V., Shutkov, I. A., Nazarov, A. A., Gorshkov, M. V., & Tarasova, I. A. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00718 · Cited by 4 · see citing works

Inhibition of human maltase-glucoamylase, sucrase-isomaltase and α-amylases by gallotannins and ellagitannins

Farazi, M., Houghton, M. J., Murray, M., Cardoso, B. R., & Williamson, G. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144204 · Cited by 3 · see citing works

Lonidamine Increases the Cytotoxic Effect of 1-[(4-Amino-2-methyl-5-pyrimidinyl)methyl]-3-(2-chloroethyl)-3-nitrosourea via Energy Inhibition, Disrupting Redox Homeostasis, and Downregulating MGMT Expression in Human Lung Cancer Cell Line

Fan, T., Shen, L., Huang, Y., Wang, X., Zhao, L., Zhong, R., Wang, P., & Sun, G. (2024) · ACS Omega · doi:10.1021/acsomega.4c00641 · Cited by 3 · see citing works

Design, Synthesis, and Biological Evaluation of Naphthoquinone Salts as Anticancer Agents

Cheng, Y., Yu, T. T., Olzomer, E. M., Hoehn, K. L., Byrne, F. L., Kumar, N., & Black, D. S. (2025) · Molecules · doi:10.3390/molecules30091938 · Cited by 3 · see citing works

Design and synthesis of multitarget triazinoindole derivatives with potent antiproliferative activity: Targeting EGFR, SIRT1, MDM2, Hsp90, PI3K, p53, and caspase-9

Badawi, W. A., Ezz-ElDien, E. S., El‐Atawy, M. A., Omar, A. Z., Hamed, E. A., Ahmed, H. A., Jaremko, M., Emwas, A.-H. M., Okda, T. M., El-Readi, M. Z., et al. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108943 · Cited by 4 · see citing works

Carrier-free prodrug nanoparticles based on lonidamine and cisplatin for synergistic treatment of breast cancer

Lü, Y., Li, J., Guan, Z., Zhang, J., Wang, X., & Tang, R. (2022) · Journal of Biomaterials Applications · doi:10.1177/08853282221107951 · Cited by 3 · see citing works

Targeting glycolytic enzymes to combat cancer metastasis: Strategies toward clinical translation

Zhang, D., He, Y., & He, Y. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117499 · Cited by 2 · see citing works

A targeted pyroptosis nanoamplifier for boosting αPD-1 neoadjuvant immunotherapy in colorectal cancer

Zhou, Y., Zhang, Z., Deng, W., Huang, J., Liu, W., Jin, C., Zhang, J., Chen, W., & Xu, C. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.173030 · Cited by 2 · see citing works

Lactate targeting: Regulatory networks and therapeutic potential in bone diseases

Zhang, X., Yan, X., Gao, W., Ma, J., Wu, Z., An, N., Qiu, L., & 郭佳杰 (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116376 · Cited by 2 · see citing works

Development of Potent ERα Inhibitors: Effectively Inhibit the Growth of Breast Cancer Cells

Yao, W., Wang, P., Yang, H., Pu, X., & Yang, J. (2022) · ChemistrySelect · doi:10.1002/slct.202201451 · Cited by 2 · see citing works

Ketogenic Diet Therapy for Glioma: Combined Effects

Qin, H., Zhang, F., & Gao, S. (2023) · Current Cancer Therapy Reviews · doi:10.2174/1573394719666230717160843 · Cited by 2 · see citing works

Targeting HK2 in Anticancer Therapy

Walczak, K. (2024) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2024.56.008847 · Cited by 2 · see citing works

Targeting Metabolic Reprogramming: A New Frontier in Cancer Therapy

Thakur, R. K., & Kumari, N. (2025) · Springer eBooks · doi:10.1007/978-981-96-7336-0_9 · Cited by 1 · see citing works

Deciphering enemy tactics – the narrow path to an optimal anti-cancer strategy targeting the Warburg effect

Kocemba‐Pilarczyk, K. A., Ostrowska, B., Trojan, S., & Dudzik, P. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00768-9 · Cited by 2 · see citing works

Metabolism‐Regulating Nanomedicines for Cancer Therapy

Wu, X., Geng, S., & Yang, J. Y. (2025) · Advanced NanoBiomed Research · doi:10.1002/anbr.202500105 · Cited by 1 · see citing works

The Interventional Effects and Mechanisms of Lonidamine in Combination with Apigenin on Colorectal Cancer

Zhou, Y., Shi, J., Zhang, M., Yang, H., & Fei, J. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47100825 · Cited by 1 · see citing works

In vitro and in vivo potentiation by lonidamine of the antitumor effect of adriamycin.

Zupi, G., Greco, C., Laudonio, N., Benassi, M., Silvestrini, B., & Caputo, A. (1986) · PubMed · Cited by 48 · see citing works

Mechanism of antineoplastic activity of lonidamine

Nath, K., Guo, L., Nancolas, B., NELSON, D. S., Shestov, A. A., Lee, S., Roman, J., Zhou, R., Leeper, D. B., Halestrap, A. P., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.08.001 · Cited by 213 · see citing works

Potentiation of Antiproliferative Drug Activity by Lonidamine in Hepatocellular Carcinoma Cells

Ricotti, L., Tesei, A., Paola, F. D., Milandri, C., Amadori, D., Frassineti, G. L., Ulivi, P., & Zoli, W. (2003) · Journal of Chemotherapy · doi:10.1179/joc.2003.15.5.480 · Cited by 11 · see citing works

In vitro effect of lonidamine on the cytotoxicity of mitomycin C and BCNU in human colon adenocarcinoma cells

Villa, R., Zaffaroni, N., Orlandi, L., Bearzatto, A., da Costa, A. L. T., & Silvestrini, R. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)e0162-w · Cited by 13 · see citing works

Lonidamine, a New Approach to Cancer Therapy

Caputo, A., & Silvestrini, B. (2009) · Oncology · doi:10.1159/000225878 · Cited by 27 · see citing works